MedPath
HSA Approval

LORIDIN RAPITAB 10 mg

SIN12029P

LORIDIN RAPITAB 10 mg

LORIDIN RAPITAB 10 mg

July 19, 2002

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

R06AX13

loratadine

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

CADILA HEALTHCARE LTD

Active Ingredients

LORATADINE

10 mg

Loratadine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LORIDIN RAPITAB 10 mg - HSA Approval | MedPath